GRIN2B-related neurodevelopmental disorder

From Food & Medicine Encyclopedia


GRIN2B-related neurodevelopmental disorder
Synonyms GRIN2B-NDD
Pronounce N/A
Specialty N/A
Symptoms Developmental delay, intellectual disability, autism spectrum disorder, epilepsy, hypotonia, movement disorders
Complications N/A
Onset Infancy or early childhood
Duration Lifelong
Types N/A
Causes Genetic mutation in the GRIN2B gene
Risks Family history of genetic disorders
Diagnosis Genetic testing, clinical evaluation
Differential diagnosis Other neurodevelopmental disorders
Prevention N/A
Treatment Symptomatic treatment, supportive care
Medication N/A
Prognosis Variable, depends on severity
Frequency Rare
Deaths N/A


GRIN2B-related neurodevelopmental disorder is a rare genetic condition that affects the neurodevelopment of an individual. It is characterized by a range of symptoms including intellectual disability, developmental delay, and often, autism spectrum disorder (ASD). The disorder is caused by mutations in the GRIN2B gene, which plays a crucial role in the functioning of the nervous system.

Symptoms and Diagnosis[edit]

The symptoms of GRIN2B-related neurodevelopmental disorder vary widely among affected individuals. Common symptoms include intellectual disability, developmental delay, and often, autism spectrum disorder. Other symptoms may include epilepsy, hypotonia (low muscle tone), and dysmorphic features. Diagnosis of GRIN2B-related neurodevelopmental disorder is typically made through genetic testing, which can identify mutations in the GRIN2B gene. This is often done as part of a larger genetic testing panel for neurodevelopmental disorders.

Genetics[edit]

GRIN2B-related neurodevelopmental disorder is caused by mutations in the GRIN2B gene. This gene provides instructions for making a protein that is part of NMDA receptors, which play a key role in the brain. These receptors are involved in the signaling between nerve cells, and are crucial for learning and memory. Mutations in the GRIN2B gene disrupt the normal functioning of NMDA receptors, which can lead to the symptoms seen in GRIN2B-related neurodevelopmental disorder.

Treatment and Management[edit]

There is currently no cure for GRIN2B-related neurodevelopmental disorder. Treatment is symptomatic and supportive, and may include physical therapy, occupational therapy, and speech therapy. Medications may be used to manage symptoms such as epilepsy.

See Also[edit]

References[edit]

This article is a stub related to genetics. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.